Dr. Keidar receives $50,000 NSF grant

Dr. Michael Keidar has received a $50,000 National Science Foundation grant for his project “ICorps: Cold Plasma Cancer Therapy.”  The award runs from April through September of this year.   The fundamental significance of the proposed work is in exploring the medical action of Cold Atmospheric Plasma (CAP), in particular, CAP interaction with tumors.  The technical part of the project will focus on developing a prototype system for clinical trials.  Prof. Keidar’s team also will initiate discussions with the Federal Drug Administration about necessary steps to approve the device for clinical use.